Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
CNVS · 10-Q filed August 13, 2026

CNVS earnings analysis

What we found in CNVS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Revenue grew 62.5% year over year to $26 million and diluted EPS improved to $0.08 from $0.04, but profitability and cash generation weakened materially. Gross margin declined to 40.0% from 54.8% a year earlier, operating margin fell to negative 20.8% from positive 13.7%, and free cash flow was negative $7 million versus positive $12 million. The 10-Q provides no quantitative guidance and reports no material changes to the prior 10-K risk factors.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue grew 62.5% sequentially
Revenue increased to $26 million from $16 million in 2026Q3, a 62.5% sequential increase, and was also up 62.5% from $16 million in 2025Q4.
EPS returned to positive territory
Diluted EPS improved to $0.08 from a $(0.05) loss in 2026Q3 and $0.04 in 2025Q4.
Revenue growth came with margin pressure
Gross margin was 40.0%, representing a 29.0 percentage-point decline from 69.0% in 2026Q3, but remained below the prior-year level of 54.8%.
No new material risk-factor changes
The filing reports no material changes to the risk factors disclosed in the fiscal-year 2026 Form 10-K, which covered the year ended March 31, 2026.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Operating losses widened
Operating margin deteriorated to negative 20.8% from negative 4.0% in 2026Q3 and positive 13.7% in 2025Q4, indicating that the quarter's revenue growth did not translate into operating profitability.
Cash generation remained negative
Free cash flow was negative $7 million, versus negative $2 million in 2026Q3 and positive $12 million in 2025Q4, signaling weaker cash generation despite the EPS improvement.
Sharp gross-margin contraction
Gross margin fell to 40.0% from 69.0% sequentially and 54.8% year over year, creating material pressure on operating leverage.
No quantified new risk disclosed
The 10-Q states there were no material changes to the risk factors in Item 1A of the March 31, 2026 Form 10-K; therefore, this filing does not identify a newly added or modified risk with a quantified impact.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $60 Operating expenses $61 Left as operating profit $-21
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$0.08
Gross margin
40.0%
Operating margin
-20.8%
Guidance

What they said about what is next.

The 10-Q does not provide quantitative revenue or EPS guidance. Previously reported FY2027 outlook was discussed outside this filing.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-K · June 26, 2026
Cineverse Corp. reported a decline in revenue for the year ended March 31, 2026, totaling $65.7 million, a decrease of 16% from the previous year, primarily due to a reduction in base distribution and streaming…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing CNVS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever